BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset

CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review

(2016) Kavitha Kothur et al.   CYTOKINE

BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset

(2016) M. Puthenparampil et al.   JOURNAL OF NEUROIMMUNOLOGY

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

(2016) Massimo Filippi et al.   LANCET NEUROLOGY

Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset

(2014) Dario Seppi et al.   JOURNAL OF NEUROIMMUNOLOGY

The Charcot Lecture | Beating MS: A story of B cells, with twists and turns

(2014) Stephen L Hauser   Multiple Sclerosis Journal

Intrathecal oligoclonal IgG synthesis in multiple sclerosis

(2013) Axel Petzold   JOURNAL OF NEUROIMMUNOLOGY

B cells and antibodies in multiple sclerosis pathogenesis and therapy

(2012) Markus Krumbholz et al.   Nature Reviews Neurology

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis

(2011) Owain W. Howell et al.   BRAIN

Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time

(2011) Xiaoli Yu et al.   JOURNAL OF NEUROIMMUNOLOGY

Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin

(2011) Birgit Obermeier et al.   JOURNAL OF NEUROIMMUNOLOGY

Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid

(2011) Samia Ragheb et al.   Multiple Sclerosis Journal

Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis

(2010) O. Thaunat et al.   BLOOD

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

(2010) Mohsen Khademi et al.   Multiple Sclerosis Journal

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid

(2009) Gregory P. Owens et al.   ANNALS OF NEUROLOGY

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE